Exchange: NASDAQ·Updated 07:30 PM EDT
MESO logo

MESO Mesoblast limited.

$17.29
$0.79
(4.79%)
Today
Closed $17.29
$0.00
(0.00%)
After Hours
EarningsFeb 25
Mkt Cap$2.25B
Vol296,627.00

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
44

Bearish Sentiment

How do you feel about MESO?

Advertisement|Remove ads.